Ryanodine receptor mutations in malignan
โ
Tommie V. McCarthy; Kathleen A. Quane; Patrick J. Lynch
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 259 KB
๐ 2 views
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that manifests in response to anesthetic triggering agents. Central core disease (CCD) is a myopathy closely associated with MH. Both MH and CCD are primarily disorders of calcium regulation in skeletal muscle. The ryanodin